Selpercatinib in Patients With RET Fusion-Positive Non-Small-Cell Lung Cancer: Updated Safety and Efficacy From the Registrational LIBRETTO-001 Phase I/II Trial - Drilon, A; Subbiah, V; Gautschi, O (J Clin Oncol, 2023)
et al.